Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings
Source abstract
Abstract
Parathyroid hormone-related protein (107-111) (osteostatin) induces osteogenic effects in osteoblasts in vitro and in regenerating bone in mice and rabbits. In this study we used osteoblastic MC3T3-E1 cell cultures to evaluate and compare the bioactivity of this peptide either adsorbed or covalently bound (by its C-terminus) to Si-doped hydroxyapatite (Si-HA) scaffolds after organic (-NH(2)) functionalization. By these means osteostatin can be locally released or kept anchored to the scaffold surface. This was confirmed by chemical analysis and by testing the efficiency of osteostatin-loaded Si-HA scaffolds (placed in Transwell chambers) in healing a scratch wound in mouse pluripotent mesenchymal C3H10T1/2 cells. Our results show that exposure of MC3T3-E1 cell monolayers to Si-HA scaffolds with both types of osteostatin coating (deliverable or immobilized), in contrast to those without peptide, similarly stimulated cell growth and matrix mineralization. These findings demonstrate that osteostatin release from Si-HA scaffolds is not essential to promote osteoblastic growth and function in vitro, and lend credence to considering osteostatin a bone regenerating factor.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthodontics and Dentofacial Orthopedics · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Biological apatites in bone and teeth
2. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone10.1016/0142-9612(96)85762-0 ↗
3. Nanostructured biomaterials for regeneration10.1002/adfm.200800662 ↗
4. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
5. Biomedical applications
6. Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs10.1016/S0142-9612(03)00030-9 ↗
7. In vitro bioactivity of silicon-substituted hydroxyapatites10.1002/jbm.a.10579 ↗
8. Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation10.1016/j.actbio.2009.08.033 ↗
9. Biocompatibility and drug delivery systems10.1039/C0SC00203H ↗
10. The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model10.1016/j.biomaterials.2010.07.103 ↗
11. Silicon incorporation in hydroxylapatite obtained by controlled crystallization10.1021/cm035337p ↗
12. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine)10.1021/ja00076a077 ↗
13. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial10.1002/(SICI)1097-4636(19970615)35:4<513::AID-JBM11>3.0.CO;2-C ↗
14. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107–111) and (107–139), on osteoblastic osteosarcoma cells10.1002/(SICI)1097-4652(199702)170:2<209::AID-JCP13>3.0.CO;2-C ↗
15. The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low turnover osteopaenia10.1111/j.1476-5381.2010.01155.x ↗
16. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells10.1210/en.2003-0273 ↗
17. Fluorescence-based quantitative scratch wound healing assay demonstrating the role of MAPKAPK-2/3 in fibroblast migration10.1002/cm.20418 ↗
18. CellProfiler™: free, versatile software for automated biological image analysis10.2144/000112257 ↗
19. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation10.1083/jcb.114.5.1089 ↗
20. Infrared studies of apatites. II. Preparation of normal and isotopically substituted calcium, strontium, and barium hydroxyapatites and spectra–structure–composition correlations10.1021/ic50131a040 ↗
21. Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing10.1021/bi00189a054 ↗
22. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides10.1359/jbmr.2000.15.7.1266 ↗
23. Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide 107–139 as a substrate and osteocalcin, PPi and phosphate as inhibitors10.1042/bj3550707 ↗
24. Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein10.1359/jbmr.1999.14.6.915 ↗
25. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of PTHrP (107–111)10.1210/endo-129-6-3424 ↗
26. C-terminal parathyroid hormone-related protein (PTHrP) (107–139) stimulates intracellular Ca2+ through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells10.1210/en.142.7.2752 ↗
27. Structure study of osteostatin PTHrP[Thr107](107–139)10.1016/S0167-4838(99)00078-3 ↗
28. Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein10.1002/jcb.240540203 ↗